T1	Participants 755 851	Seventy-eight patients with AFF and a ventricular rate of >/= 120 beats per minute were enrolled
T2	Participants 118 154	atrial fibrillation or flutter (AFF)
T3	Participants 1292 1402	One patient in the placebo group became paradoxically more tachycardic and apneic after the diltiazem infusion
